U.S. Aerospace & Defense Stock News

NYSE:GAP
NYSE:GAPSpecialty Retail

Does Gap’s DoorDash Back‑to‑School Tie‑Up Reframe Its Margin‑Focused Turnaround Story (GAP)?

In August 2026, DoorDash, Inc. and Gap announced a nationwide partnership enabling rapid delivery of Gap and Gap Factory apparel from participating stores, supported by limited-time back-to-school discounts for qualifying orders fulfilled via DoorDash. This collaboration extends Gap’s reach into on-demand retail, giving the brands access to DoorDash’s fast-growing marketplace and large U.S. customer base at a key seasonal spending period. Next, we’ll examine how adding on-demand DoorDash...
NasdaqGS:CTRN
NasdaqGS:CTRNSpecialty Retail

3 U.S. Small Cap Retail Stocks to Watch Before Consumer Confidence Data Hits

With fresh readings on consumer confidence and inflation about to hit, Wall Street is reassessing how resilient household spending really is and what that could mean for small consumer stocks. That creates an opening for investors who want to position ahead of any swing in sentiment rather than react after the fact. This article walks through three U.S. small cap consumer discretionary retailers exposed to this news, and why they deserve a closer look now. The three stocks below are just a...
NYSE:SFBS
NYSE:SFBSBanks

What Is Drawing Attention To ServisFirst Bancshares (SFBS) Today?

ServisFirst Bancshares stock reaction and recent return profile ServisFirst Bancshares (SFBS) has drawn investor attention after recent trading, with the stock last closing at $43.34. Short term performance has been mixed, with the share price down over the past week but roughly flat over the past month. See our latest analysis for ServisFirst Bancshares. Over a longer horizon, ServisFirst Bancshares has delivered a 67.59% three year total shareholder return and a 27.25% five year total...
NYSE:BIO
NYSE:BIOLife Sciences

Why Bio-Rad Laboratories (BIO) Is Up 6.7% After Restructuring Move Amid Mixed Segment Trends

In recent weeks, Bio-Rad Laboratories reported continued growth in its digital PCR business, supported by strong instrument sales and contributions from the Stilla Technologies portfolio, while its Life Science segment faced softer demand and the company maintained a cautious full-year 2026 revenue and margin outlook. At the same time, management has launched a restructuring program aimed at delivering cost savings and lifting operating margins by 2027, highlighting a shift toward efficiency...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

PROCEPT BioRobotics (PRCT) Faces Lawsuit Scrutiny After Revenue Claims So Is It A Buying Opportunity

Recent securities class action filings against PROCEPT BioRobotics (PRCT) accuse the company of misleading investors on handpiece sales, undisclosed discount programs, and inflated revenue. The allegations are raising fresh questions around its reported growth, guidance cuts, and stock volatility. See our latest analysis for PROCEPT BioRobotics. The recent wave of lawsuits helps explain why PROCEPT BioRobotics has had a weak year to date, with the stock showing a 30 day share price return of...
NYSE:IVZ
NYSE:IVZCapital Markets

What Invesco (IVZ)'s New Solutions Platform and Real Estate Fee Cuts Mean For Shareholders

In August 2026, Invesco Ltd. introduced Invesco Solutions & Custom Strategies, a unified global platform that combines its public and private market capabilities across active and passive strategies, alongside custom models and separately managed accounts, while also cutting management fees and offering discounted redemptions plus up to US$150 million of added capital to ease a backlog in its US$12.70 billion Invesco Core Real Estate, USA fund. This combination of a more integrated,...
NYSE:UBER
NYSE:UBERTransportation

Uber (UBER) Stock May Be Reasonable On Fresh Robotaxi Expansion News

Uber Technologies stock has delivered a strong 93.7% return over the past 5 years, yet its current valuation checks and recent share price performance raise questions about how much upside is still on the table. With mixed signals from recent news, including regulatory scrutiny and expansion into autonomous and drone services, investors are weighing how much of Uber’s long term story is already reflected in the price. Over 5 years, Uber Technologies has returned 93.7%, which puts the current...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

Zenas BioPharma (ZBIO) Is Up 9.4% After Wider Losses And Board Addition - Has The Bull Case Changed?

In August 2026, Zenas BioPharma, Inc. reported second-quarter and first-half 2026 results showing US$1,000,000 in quarterly revenue and a sharply higher net loss of US$111,460,000, while also announcing the upcoming transition of Chief Financial Officer Jennifer Fox to a Strategic Advisor role and interim financial leadership by President and COO Joe Farmer. At the same time, Zenas added industry veteran Christy Oliger to its board, bringing extensive commercial experience from leading large...
NYSE:M
NYSE:MMultiline Retail

Is Macy's (M) Fully Valued Ahead Of Its September 10 Earnings?

Macy's (M) is back in focus after its stock closed at $22.58, a 3.5% decline from the prior session, ahead of the retailer's September 10, 2026 earnings release. See our latest analysis for Macy's. The recent 1 day share price return of 1.06% to $22.82 comes after a weaker 30 day share price return of 6.21% and a much stronger 1 year total shareholder return of 74.41%. This suggests long term momentum while short term sentiment has cooled ahead of Macy's upcoming earnings. If Macy's recent...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Medpace Holdings (MEDP) Rallies As Valuation Questions Grow

Medpace Holdings (MEDP) has drawn fresh attention after recent share price moves, with the stock closing at $620.75 on 19 August 2026. Investors are assessing how this valuation lines up with the company’s fundamentals. See our latest analysis for Medpace Holdings. For context, Medpace Holdings has logged a 17.54% 1 month share price return and a 43.43% 3 month share price return, while the 1 year total shareholder return is 33.89% and the 5 year total shareholder return is 243.64%. This...
NYSE:BX
NYSE:BXCapital Markets

Blackstone (BX) Is Getting Fresh Attention, What Is Behind It?

Blackstone (BX) is back in focus after NVIDIA announced new partnerships on August 10, 2026, to create compute financing platforms intended to mobilize over $500b of third party capital for AI infrastructure. See our latest analysis for Blackstone. For context, Blackstone's 30 day share price return of 16.7% and 90 day gain of 21.0% point to building momentum, even though the year to date share price is still down 9.7% and the 1 year total shareholder return is down 12.5%. At the same time,...
NYSE:MET
NYSE:METInsurance

MetLife (MET) Faces Q2 Valuation Questions, Is The Stock Fully Priced?

MetLife preferred dividend declaration and what it means for investors MetLife (MET) declared a fresh set of preferred stock dividends for the third quarter of 2026, a routine capital allocation move that gives investors more detail on the company’s funding and payout structure. The board approved payments on several non cumulative preferred series, with different coupon structures and liquidation preferences that appeal to distinct investor income needs. These dividends are scheduled to be...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

Founder Led Stocks With Insider Alignment Worth Watching

With central banks signaling a cautious stance as inflation risks linger, investors are again paying close attention to who is actually steering the companies they own. Founder led businesses often keep a sharper eye on capital allocation and long term reputation. That can matter when money feels more expensive. This article highlights three founder led stocks from our screener that show how aligned leadership can shape potential resilience. The stocks below are just a starter set, and the...
NYSE:PM
NYSE:PMTobacco

What Is Drawing Fresh Attention To Philip Morris International (PM)?

Philip Morris International (PM) is back in focus after the U.S. FDA granted Marketing Granted Orders for 11 ZYN ULTRA moist oral nicotine pouch products, expanding the company’s regulated smoke free portfolio. See our latest analysis for Philip Morris International. The FDA approval arrives after a run of steady news from Philip Morris International, including Q2 2026 results that met market expectations and a recent ZYN-branded art initiative in the U.S. While the share price has softened...
NYSE:TEL
NYSE:TELElectronic

Why TE Connectivity (TEL) Is Down 5.9% After Earnings Beat And US$1.4 Billion Astrodyne Deal

TE Connectivity recently reported fiscal third-quarter 2026 results, with adjusted earnings of US$2.94 per share and 14% higher net sales year over year, alongside record orders of US$5.70 billion driven by Industrial and Transportation demand. The company also agreed to acquire Astrodyne TDI for about US$1.40 billion, a move that broadens its power-management capabilities within Industrial Solutions and may enhance its role in higher-value electrification and energy applications. We’ll now...
NYSE:GEV
NYSE:GEVElectrical

3 Nuclear Energy Stocks Riding The Push For Reliable Power

Global bond yields are feeling the strain of persistent energy driven inflation risk, which keeps attention on power security and long term supply. That puts nuclear energy stocks back on many watchlists as investors look for power sources that are not directly tied to volatile fuel markets. This article highlights 3 nuclear energy stocks from our screener that help turn that broad theme into specific ideas to research. The three nuclear energy stocks below are just a sample from this theme...
NasdaqGS:PENN
NasdaqGS:PENNHospitality

What PENN Entertainment (PENN)'s US$195 Million New Orleans Casino Relocation Means For Shareholders

PENN Entertainment has announced plans, dating back to August 2026, to invest approximately US$195,000,000 to relocate its Boomtown Casino & Hotel New Orleans to an adjacent landside site, rebranding it as Hollywood Casino New Orleans with a new gaming floor, sportsbook, and expanded amenities, pending regulatory approval. This fourth landside relocation project, to be funded primarily with cash on hand while keeping the existing hotel open, highlights PENN’s focus on organic growth and...
NYSE:SNDA
NYSE:SNDAHealthcare

Sonida Senior Living (SNDA) Posted Strong Revenue Growth, Is The Wider Loss Already Priced In?

Sonida Senior Living (SNDA) is back in focus after its latest quarterly update, which showed sharply higher revenue alongside a significantly wider net loss. That mix is prompting fresh questions about the stock’s risk and reward profile. See our latest analysis for Sonida Senior Living. Over the past year Sonida Senior Living has drawn fresh attention, with the share price at US$39.56 and a year to date share price return of 23.9% alongside a very large 3 year total shareholder return of...
NasdaqGS:JKHY
NasdaqGS:JKHYDiversified Financial

Jack Henry (JKHY) Is Up 8.4% After Stronger 2027 Guidance And New AI Core Win – What's Changed

Earlier this month, Jack Henry & Associates reported past fourth-quarter and fiscal 2026 results showing higher sales year on year but softer quarterly earnings, alongside new fiscal 2027 guidance and an update on a long-running share repurchase program totaling about US$2.38 billion. A few days later, Prevail Bank announced it had chosen Jack Henry’s core system, digital banking, and AI-enabled fraud and workflow tools, underscoring how the company’s open ecosystem and AI capabilities are...